Moses Makunje

Comptroller/Controller/Auditor at NUVATION BIO INC.

Net worth: 325 695 $ as of 2026-05-30

48 year

Health Technology

Consumer Services

Profile

Moses Makunje is currently VP-Finance & Principal Accounting Officer at Nuvation Bio, Inc. since 2020.
Formerly, Mr. Makunje was Controller at Adverum Biotechnologies, Inc. from 2017 to 2019 and Controller at Maze Therapeutics, Inc. from 2019 to 2020.
Mr. Makunje completed undergraduate and MBA degrees at Golden Gate University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NUVATION BIO, INC. CLASS A 0.02%	2026-02-26	68,137 ( 0.02% )	325 695 $	2026-05-30

Moses Makunje active positions

Companies	Position	Start
NUVATION BIO INC.	Comptroller/Controller/Auditor	2023-11-26

All active positions of Moses Makunje

Former positions of Moses Makunje

Companies	Position	End
Maze Therapeutics, Inc. Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases	Comptroller/Controller/Auditor	2020-06-30
ADVERUM BIOTECHNOLOGIES, INC.	Comptroller/Controller/Auditor	2019-02-28

See the detail of Moses Makunje's experience

Training of Moses Makunje

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Moses Makunje's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Golden Gate University Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adverum Biotechnologies, Inc. Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies	Health Technology
Maze Therapeutics, Inc. Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases	Health Technology
Nuvation Bio, Inc. Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates	Health Technology